Jump to content

OmniVis: Difference between revisions

Add links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous edit
Content deleted Content added
VisualWikitext
No edit summary
GreenC bot (talk | contribs)
Bots
2,552,698 edits
 
(6 intermediate revisions by 5 users not shown)
Line 12: Line 12:
}}
}}
[[File:TechCrunch Disrupt San Francisco 2019 - Day 1 (48834421858).jpg|thumb|Dr Katherine Clayton of OmniVis at [[TechCrunch]] Disrupt San Francisco 2019]]
[[File:TechCrunch Disrupt San Francisco 2019 - Day 1 (48834421858).jpg|thumb|Dr Katherine Clayton of OmniVis at [[TechCrunch]] Disrupt San Francisco 2019]]
'''OmniVis''' is a [[South San Francisco]] based biotechnology company that specializes in rapid [[Medical diagnosis|medical diagnostic]] tests.<ref name=":0">{{Cite news|last=Joe Palca and Susie Neilson|date=7 Aug 2019|title=This Handy New Device Might Help KO Cholera|language=en|work=NPR.org|url=https://www.npr.org/sections/goatsandsoda/2019/08/07/749100484/this-handy-new-device-might-help-kayo-cholera|access-date=2021-10-31}}</ref><ref>{{Cite web|date=2019-02-15|title=Purdue Spinout OmniVis Commercializing Smartphone-Based Cholera Test|url=https://www.genomeweb.com/pcr/purdue-spinout-omnivis-commercializing-smartphone-based-cholera-test|access-date=2021-11-02|website=Genomeweb|language=en}}</ref><ref>Prashantham, Shameen. Gorillas Can Dance: Lessons from Microsoft and Other Corporations on Partnering with Startups. United Kingdom: Wiley, 2021. p.p. lviii</ref>
'''OmniVis''' is a [[South San Francisco]] based biotechnology company that specializes in rapid [[Medical diagnosis|medical diagnostic]] tests.<ref name=":0">{{Cite news|last=Joe Palca and Susie Neilson|date=7 Aug 2019|title=This Handy New Device Might Help KO Cholera|language=en|work=NPR.org|url=https://www.npr.org/sections/goatsandsoda/2019/08/07/749100484/this-handy-new-device-might-help-kayo-cholera|access-date=2021-10-31}}</ref><ref>{{Cite web|date=2019-02-15|title=Purdue Spinout OmniVis Commercializing Smartphone-Based Cholera Test|url=https://www.genomeweb.com/pcr/purdue-spinout-omnivis-commercializing-smartphone-based-cholera-test|access-date=2021-11-02|website=Genomeweb|language=en}}</ref><ref>Prashantham, Shameen. Gorillas Can Dance: Lessons from Microsoft and Other Corporations on Partnering with Startups. United Kingdom: Wiley, 2021. p.p. lviii</ref> Co-founded by Dr. Katherine Clayton, a Purdue College of Engineering graduate alumna, and three professors, OmniVis produces cholera test and is working on COVID-19 tests.

They produce plug-and-play diagnostic devices and test kits for cholera that will soon be used for other diseases.


== Products ==
== Products ==


=== Cholera detection ===
=== Cholera detection ===
OmnniVis's rapid [[Cholera]] detection device can identify the presence of ''[[Vibrio cholerae]]'' in water in less than one hour (35 minutes average on one study and 47 minutes in another), whereas previous technologies take five to seven days.<ref>{{Cite journal|last1=Rager|first1=Theresa L.|last2=Koepfli|first2=Cristian|last3=Khan|first3=Wasif A.|last4=Ahmed|first4=Sabeena|last5=Mahmud|first5=Zahid Hayat|last6=Clayton|first6=Katherine N.|date=2021-05-12|title=Usability of Rapid Cholera Detection Device (OmniVis) for Water Quality Workers in Bangladesh: Iterative Convergent Mixed Methods Study|url=https://www.jmir.org/2021/5/e22973|journal=Journal of Medical Internet Research|language=EN|volume=23|issue=5|pages=e22973|doi=10.2196/22973|pmid=33978590|pmc=8156127}}</ref><ref>{{Cite journal|last1=Moehling|first1=Taylor J|last2=Lee|first2=Dong Hoon|last3=Henderson|first3=Meghan E|last4=McDonald|first4=Mariah K|last5=Tsang|first5=Preston H|last6=Kaakeh|first6=Seba|last7=Kim|first7=Eugene S|last8=Wereley|first8=Steven T|last9=Kinzer-Ursem|first9=Tamara L|last10=Clayton|first10=Katherine N|last11=Linnes|first11=Jacqueline C|date=2020-11-01|title=A smartphone-based particle diffusometry platform for sub-attomolar detection of Vibrio cholerae in environmental water|journal=Biosensors & Bioelectronics|volume=167|pages=112497|doi=10.1016/j.bios.2020.112497|issn=1873-4235|pmc=7532658|pmid=32836088}}</ref> The device uses a process of [[Gene amplification|DNA amplification]] and [[viscosity]] measurement and costs approximately US$10 per test.<ref name=":2">{{Cite web|last=Coldewey|first=Devin|date=2 Oct 2019|title=OmniVis could save lives by detecting cholera-infected water in minutes rather than days|url=https://social.techcrunch.com/2019/10/02/omnivis-could-save-lives-by-detecting-cholera-infected-water-in-minutes-rather-than-days/|url-status=live|access-date=2021-10-31|website=TechCrunch|language=en-US}}</ref>
OmnniVis's rapid [[Cholera]] detection device can identify the presence of ''[[Vibrio cholerae]]'' in water in less than one hour.<ref>{{Cite web |last=Service |first=Purdue News |title=‘Cholera detection lab’ smartphone-enabled platform to be beta tested by worldwide leading hospital in cholera research |url=https://www.purdue.edu/newsroom/releases/2019/Q3/cholera-detection-lab-smartphone-enabled-platform-to-be-beta-tested-by-worldwide-leading-hospital-in-cholera-research.html |access-date=2023-11-20 |website=www.purdue.edu |language=en}}</ref> The device uses a process of [[Gene amplification|DNA amplification]] and [[viscosity]] measurement.<ref name=":2">{{Cite web|last=Coldewey|first=Devin|date=2 Oct 2019|title=OmniVis could save lives by detecting cholera-infected water in minutes rather than days|url=https://techcrunch.com/2019/10/02/omnivis-could-save-lives-by-detecting-cholera-infected-water-in-minutes-rather-than-days/|access-date=2021-10-31|website=TechCrunch|language=en-US}}</ref>

The processing is done on a handheld device that analyzes water samples inserted into a single-use test kit.<ref name=":0" />


The processing is done via a smartphone enabled platform that analyzes water samples inserted into a single-use test kit element.<ref name=":0" /> In May 2019, OmniVis teamed up with the International Cetre for Diarrhoeal Disease Research, Bangladesh to beta test the technology.<ref name=":0" />
The current design uses a novel method to address the problem of detecting a disease in a small volume of sample.<ref name=":0" />


=== COVID-19 detection ===
=== COVID-19 detection ===
In May 2020, OmniVis was working on the early stages of a [[Rapid diagnostic test|rapid test]] for [[COVID-19]]<ref name=":3">{{Cite news|last=Marcus|first=Brianna Abbott and Amy Dockser|date=2020-05-26|title=Race Is On to Create Rapid Covid-19 Tests for the Fall|language=en-US|work=Wall Street Journal|url=https://www.wsj.com/articles/race-is-on-to-create-rapid-covid-19-tests-for-the-fall-11590494400|access-date=2021-10-31|issn=0099-9660}}</ref> that detects the disease in human saliva. The rapid tests uses a smartphone for processing.<ref name=":3" /> The project was supported by the [[United States Department of Agriculture|United Stated Department of Agriculture]].<ref>{{Cite web|title=COVID-19 Rapid Response: A Handheld Diagnostic Device for COVID-19 in Meat and Poultry Processing Facilities - OMNIVIS INC|url=https://portal.nifa.usda.gov/web/crisprojectpages/1024206-covid-19-rapid-response-a-handheld-diagnostic-device-for-covid-19-in-meat-and-poultry-processing-facilities.html|access-date=2021-12-17|website=portal.nifa.usda.gov}}</ref> From June 2020, OmniVis was also working on a United States [[National Science Foundation]] funded initiative to detect COVID-19 from nasal swabs.<ref>{{Cite web|title=NSF Award Search: Award # 2028308 - SBIR Phase I: COVID-19 Detection on a Handheld Smartphone-Enabled Platform|url=https://www.nsf.gov/awardsearch/showAward?AWD_ID=2028308&HistoricalAwards=false|access-date=2021-12-17|website=www.nsf.gov}}</ref>
In May 2020, OmniVis was working on the early stages of a [[Rapid diagnostic test|rapid test]] for [[COVID-19]]<ref name=":3">{{Cite news|last=Marcus|first=Brianna Abbott and Amy Dockser|date=2020-05-26|title=Race Is On to Create Rapid Covid-19 Tests for the Fall|language=en-US|work=Wall Street Journal|url=https://www.wsj.com/articles/race-is-on-to-create-rapid-covid-19-tests-for-the-fall-11590494400|access-date=2021-10-31|issn=0099-9660}}</ref> that detects the disease in human saliva. The rapid tests uses a smartphone for processing.<ref name=":3" /> The project was supported by the [[United States Department of Agriculture]].<ref>{{Cite web|title=COVID-19 Rapid Response: A Handheld Diagnostic Device for COVID-19 in Meat and Poultry Processing Facilities - OMNIVIS INC|url=https://portal.nifa.usda.gov/web/crisprojectpages/1024206-covid-19-rapid-response-a-handheld-diagnostic-device-for-covid-19-in-meat-and-poultry-processing-facilities.html|access-date=2021-12-17|website=portal.nifa.usda.gov}}</ref> From June 2020, OmniVis was also working on a United States [[National Science Foundation]] funded initiative to detect COVID-19 from nasal swabs.<ref>{{Cite web|title=NSF Award Search: Award # 2028308 - SBIR Phase I: COVID-19 Detection on a Handheld Smartphone-Enabled Platform|url=https://www.nsf.gov/awardsearch/showAward?AWD_ID=2028308&HistoricalAwards=false|access-date=2021-12-17|website=www.nsf.gov}}</ref>


== References ==
== References ==

Latest revision as of 04:59, 26 July 2024

OmniVis
IndustryBiotechnology
Founded2017
HeadquartersSan Francisco
Key people
Katherine Clayton, CEO
Websitewww.omnivistech.com
Dr Katherine Clayton of OmniVis at TechCrunch Disrupt San Francisco 2019

OmniVis is a South San Francisco based biotechnology company that specializes in rapid medical diagnostic tests.[1][2][3] Co-founded by Dr. Katherine Clayton, a Purdue College of Engineering graduate alumna, and three professors, OmniVis produces cholera test and is working on COVID-19 tests.

Products

[edit]

Cholera detection

[edit]

OmnniVis's rapid Cholera detection device can identify the presence of Vibrio cholerae in water in less than one hour.[4] The device uses a process of DNA amplification and viscosity measurement.[5]

The processing is done via a smartphone enabled platform that analyzes water samples inserted into a single-use test kit element.[1] In May 2019, OmniVis teamed up with the International Cetre for Diarrhoeal Disease Research, Bangladesh to beta test the technology.[1]

COVID-19 detection

[edit]

In May 2020, OmniVis was working on the early stages of a rapid test for COVID-19[6] that detects the disease in human saliva. The rapid tests uses a smartphone for processing.[6] The project was supported by the United States Department of Agriculture.[7] From June 2020, OmniVis was also working on a United States National Science Foundation funded initiative to detect COVID-19 from nasal swabs.[8]

References

[edit]
  1. ^ a b c Joe Palca and Susie Neilson (7 Aug 2019). "This Handy New Device Might Help KO Cholera". NPR.org. Retrieved 2021-10-31.
  2. ^ "Purdue Spinout OmniVis Commercializing Smartphone-Based Cholera Test". Genomeweb. 2019-02-15. Retrieved 2021-11-02.
  3. ^ Prashantham, Shameen. Gorillas Can Dance: Lessons from Microsoft and Other Corporations on Partnering with Startups. United Kingdom: Wiley, 2021. p.p. lviii
  4. ^ Service, Purdue News. "'Cholera detection lab' smartphone-enabled platform to be beta tested by worldwide leading hospital in cholera research". www.purdue.edu. Retrieved 2023-11-20.
  5. ^ Coldewey, Devin (2 Oct 2019). "OmniVis could save lives by detecting cholera-infected water in minutes rather than days". TechCrunch. Retrieved 2021-10-31.
  6. ^ a b Marcus, Brianna Abbott and Amy Dockser (2020-05-26). "Race Is On to Create Rapid Covid-19 Tests for the Fall". Wall Street Journal. ISSN 0099-9660. Retrieved 2021-10-31.
  7. ^ "COVID-19 Rapid Response: A Handheld Diagnostic Device for COVID-19 in Meat and Poultry Processing Facilities - OMNIVIS INC". portal.nifa.usda.gov. Retrieved 2021-12-17.
  8. ^ "NSF Award Search: Award # 2028308 - SBIR Phase I: COVID-19 Detection on a Handheld Smartphone-Enabled Platform". www.nsf.gov. Retrieved 2021-12-17.
[edit]
Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=OmniVis&oldid=1236711349"